German study rejects neuroblastoma screening
This article was originally published in Clinica
Executive Summary
A mass early-detection programme for neuroblastoma, a form of cancer, in children aged 10-12 months serves no purpose, claims a recent German report published earlier this month in the New England Journal of Medicine. Speaking at a conference in Bonn last week, Dr Freimut Schilling from the Olga Hospital in Stuttgart, secretary of the German model project for neuroblastoma early-detection, said that such screening was pointless as it neither reduced the number of deaths, nor the number of children reaching the advanced stage of the illness.